Optic Disc Dose Comparison Between 125I and 103Pd Collaborative Ocular Melanoma Study (COMS) Plaques Based on Current Clinical Practice

被引:0
作者
Lee, Yongsook C. [1 ]
Lin, Shih-Chi [2 ]
Kim, Yongbok [3 ]
机构
[1] Miami Canc Inst, Radiat Oncol, Miami, FL 33176 USA
[2] Norwalk Hosp, Radiat Oncol, Norwalk, CT 06856 USA
[3] Duke Univ, Radiat Oncol, Durham, NC USA
关键词
optic disc dose; 125i; 103pd; coms plaques; ocular brachytherapy; UVEAL MELANOMA; BRACHYTHERAPY; DOSIMETRY; I-125;
D O I
10.7759/cureus.15980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose The purpose of this study is to compare optic disc dose (ODD) between I-125 and Pd-103 Collaborative Ocular Melanoma Study (COMS) plaques in ocular brachytherapy. Methods A previously validated in-house brachytherapy dose calculation program was used for ODD calculations. ODD was calculated as a function of tumor margin-to-optic disc distance (DT) up to 5 mm for various tumor basal dimensions (BDs), for a prescription depth of 5 mm, and for standard and notched COMS plaques loaded with I-125 (model: IAI-125A) and Pd-103 (model: IAPd-103A) seeds. ODD calculations were repeated for prescription depths from 2 mm to 10 mm in 1 mm intervals. A prescribed dose of 85 Gy (irradiation time: 120 hours) was normalized to each prescription depth. Dose conversion factors (DCFs) for each prescription depth were calculated by taking a ratio of [total reference air kerma (TRAK) per seed](prescription depth) to [TRAK per seed](5 mm). ODD reduction by notched COMS plaques was calculated for each prescription depth by subtracting ODD for notched COMS plaques from ODD for standard COMS plaques. Results Trends of ODD as a function of DT for various BDs are similar between the two seed types in both standard and notched COMS plaques. However, due to the energy difference, there exists a transition distance (d(t)) for each BD in each plaque at which ODD for I-125 COMS plaques equals that for Pd-103 COMS plaques. For small BDs, at DT <d(t), ODD for Pd-103 COMS plaques is higher than that for I-125 COMS plaques while at DT >d(t), the opposite is observed. For the largest 1-3 BD(s), contrarily, d(t) occurs within the tumor, and thus, ODD for I-125 COMS plaques is always higher. Trends of ODD reduction by notched COMS plaques as a function of DT for various BDs are the same for the two seed types except that maximum ODD reduction by Pd-103 COMS notched plaques is larger. DCF increases with increasing prescription depth for both seed types. Conclusions There exist ODD differences between I-125 and Pd-103 COMS plaques and the differences depend on DT, BD, plaque size, and prescription depth.
引用
收藏
页数:15
相关论文
共 16 条
[1]  
[Anonymous], 1999, RAD THERAPY
[2]   Outcomes of Choroidal Melanomas Treated With Eye Physics A 20-Year Review [J].
Berry, Jesse L. ;
Dandapani, Savita V. ;
Stevanovic, Marta ;
Lee, Thomas C. ;
Astrahan, Melvin ;
Murphree, A. Linn ;
Kim, Jonathan W. .
JAMA OPHTHALMOLOGY, 2013, 131 (11) :1435-1442
[3]   Dosimetry of 125I and 103Pd COMS eye plaques for intraocular tumors: Report of Task Group 129 by the AAPM and ABS [J].
Chiu-Tsao, Sou-Tung ;
Astrahan, Melvin A. ;
Finger, Paul T. ;
Followill, David S. ;
Meigooni, Ali S. ;
Melhus, Christopher S. ;
Mourtada, Firas ;
Napolitano, Mary E. ;
Nath, Ravinder ;
Rivard, Mark J. ;
Rogers, D. W. O. ;
Thomson, Rowan M. .
MEDICAL PHYSICS, 2012, 39 (10) :6161-6184
[4]   Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis [J].
Fabian, Ido Didi ;
Tomkins-Netzer, Oren ;
Stoker, Ian ;
Arora, Amit K. ;
Sagoo, Mandeep S. ;
Cohen, Victoria M. L. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 160 (06) :1104-1110
[5]   Pd-103 versus(125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas [J].
Finger, Paul T. ;
Zhou, Di ;
Kalach, Nina ;
Semenova, Ekaterina ;
Choi, Walter .
JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) :409-416
[6]   Palladium-103 Ophthalmic Plaque Radiation Therapy for Choroidal Melanoma: 400 Treated Patients [J].
Finger, Paul T. ;
Chin, Kimberly J. ;
Duvall, Greg .
OPHTHALMOLOGY, 2009, 116 (04) :790-796
[7]   Palladium-103 plaque radiotherapy for choroidal melanoma: An 11-year study [J].
Finger, PT ;
Berson, A ;
Ng, T ;
Szechter, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05) :1438-1445
[8]   Optic disc dose reduction in ocular brachytherapy using 125I notched COMS plaques: A simulation study based on current clinical practice [J].
Lee, Yongsook C. ;
Lin, Shih-Chi ;
Kim, Yongbok .
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2020, 21 (09) :57-70
[9]   A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using 125I COMS plaques [J].
Lee, Yongsook C. ;
Lin, Shih-Chi ;
Kim, Yongbok .
RADIATION ONCOLOGY, 2018, 13
[10]   A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using 125I, 103Pd, and 131Cs and historical perspective [J].
Leonard, Kara L. ;
Gagne, Nolan L. ;
Mignano, John E. ;
Duker, Jay S. ;
Bannon, Elizabeth A. ;
Rivard, Mark J. .
BRACHYTHERAPY, 2011, 10 (04) :331-339